All Stories

  1. Omission of Chest-Wall Irradiation after Mastectomy for Breast Cancer

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2025, New England Journal of Medicine (NEJM/MMS)

    Dr Jana de Boniface

  2. Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of view

    Article • European Journal of Surgical Oncology, October 2025, Elsevier

    Dr Jana de Boniface

  3. Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study

    Article • The Breast, October 2025, Elsevier

    Dr Jana de Boniface

  4. Corrigendum to “Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study” [The Breast, Volume 83 (2025) 104537]

    Article • The Breast, October 2025, Elsevier

    Dr Jana de Boniface

  5. What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?

    Article • Radiotherapy and Oncology, October 2025, Elsevier

    Dr Jana de Boniface

  6. Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)

    Article • European Journal of Surgical Oncology, September 2025, Elsevier

    Dr Jana de Boniface, Professor Gianluca Franceschini

  7. BJS commission on the surgical management of the axilla in breast cancer

    Article • BJS, September 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  8. Local management of second breast cancer event after primary breast conserving therapy: The patient’s perspective

    Article • European Journal of Surgical Oncology, September 2025, Elsevier

    Dr Jana de Boniface

  9. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

    Article • BJS, September 2025, Oxford University Press (OUP)

    Dr Jana de Boniface, Professor Gianluca Franceschini

  10. Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial

    Article • European Journal of Cancer, August 2025, Elsevier

    Dr Jana de Boniface

  11. Impact of axillary staging after neoadjuvant chemotherapy for breast cancer on arm morbidity: one-year results from the AXSANA cohort study

    Article • BJS, August 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  12. Impact of prior radiotherapy and implant-based reconstruction on microvascular outcome in DIEP flap breast reconstruction

    Article • BJS, August 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  13. Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a large population-based cohort

    Article • BJS, August 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  14. Survival after breast conservation versus mastectomy in ductal carcinoma in situ of the breast: a population-based Swedish register study

    Article • BJS, August 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  15. Abstract P2-10-25: AXSANA: Status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  16. Abstract RF2-03: Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – results from the prospective AXSANA registry trial (NCT04373655)

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  17. Abstract P3-12-16: MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET, NCT 05559411)

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  18. Abstract P3-10-29: Start of SerMa – EUBREAST 5 (Seroma of the Mammary Gland) study (NCT05899387) - On the way to identify women at risk of developing seroma after mastectomy

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  19. Abstract PS6-06: Upstage of N-Stage by Diagnostic Axillary Lymph Node Dissection in Patients w/ Isolated Tumor Cells or Micrometastases in Sentinel/Target Lymph Node after Neoadjuvant Chemotherapy - Results from the Prospective Multicenter AXSANA / EUB...

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  20. Comparison of marking techniques for target lymph nodes in 2,596 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study (NCT04373655).

    Article • Journal of Clinical Oncology, June 2025, American Society of Clinical Oncology (ASCO)

    Dr Jana de Boniface

  21. Setting a precedent: Development of a core outcome set for locoregional treatment outcome reporting in neoadjuvant breast cancer trials.

    Article • Journal of Clinical Oncology, June 2025, American Society of Clinical Oncology (ASCO)

    Dr Jana de Boniface

  22. Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trial

    Article • BJS, May 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  23. Treatment strategies for triple-negative primary breast cancer in older women: a systematic review

    Article • JNCI Cancer Spectrum, April 2025, Oxford University Press (OUP)

    Dr Jana de Boniface

  24. Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

    Article • Breast Cancer Research and Treatment, February 2025, Springer Science + Business Media

    Dr Jana de Boniface

  25. P286: Radar localization for targeted axillary dissection in breast cancer patients undergoing primary systemic treatment: a sub-analysis of the AXSANA study

    Article • The Breast, February 2025, Elsevier

    Dr Jana de Boniface

  26. P464: Treatment Strategies for Triple-Negative Primary Breast Cancer in Older Women: A Systematic Review

    Article • The Breast, February 2025, Elsevier

    Dr Jana de Boniface

  27. Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey

    Article • Radiation Oncology Journal, December 2024, Korean Society for Therapeutic Radiology and Oncology (KAMJE)

    Dr Jana de Boniface

  28. Prediction of High Nodal Burden in Patients With Sentinel Node–Positive Luminal ERBB2-Negative Breast Cancer

    Article • JAMA Surgery, December 2024, American Medical Association (AMA)

    Dr Jana de Boniface

  29. Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial

    Article • The Lancet Regional Health - Europe, December 2024, Elsevier

    Dr Jana de Boniface

  30. ‘Balancing Challenges and Personal Resources’: A Qualitative Study of Women's Experiences of Arm Impairment After Axillary Surgery for Breast Cancer

    Article • Journal of Advanced Nursing, October 2024, Wiley

    Dr Jana de Boniface

  31. Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)

    Article • Cancers, October 2024, MDPI AG

    Dr Jana de Boniface

  32. Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review

    Article • European Journal of Surgical Oncology, October 2024, Elsevier

    Dr Jana de Boniface

  33. Surgical complications after immediate implant-based breast reconstruction for breast cancer in women over 65 years

    Article • BJS Open, September 2024, Oxford University Press (OUP)

    Dr Jana de Boniface

  34. Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial

    Article • The Lancet Oncology, September 2024, Elsevier

    Dr Jana de Boniface

  35. Timing and type of breast reconstruction in SweBRO 3: long-term outcomes

    Article • BJS, August 2024, Oxford University Press (OUP)

    Dr Jana de Boniface

  36. Quality assessment of radiotherapy in the prospective randomized SENOMAC trial

    Article • Radiotherapy and Oncology, August 2024, Elsevier

    Dr Jana de Boniface

  37. 71486 - Surgical complications after immediate implant-based breast reconstruction for breast cancer in women ≥ 65 years of age

    Article • BJS, August 2024, Oxford University Press (OUP)

    Dr Jana de Boniface

  38. 71487 - The role of previous implant-based breast reconstruction and radiotherapy for surgical complications in DIEP breast reconstruction

    Article • BJS, August 2024, Oxford University Press (OUP)

    Dr Jana de Boniface

  39. Abstract PO4-19-04: AXSANA – EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  40. Abstract PO5-19-02: I-PREPARE: International Prospective REgistry on Pre-pectorAl breast Reconstruction (EUBREAST 11R-NCT 05817175)

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  41. Abstract PO4-18-12: MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET, NCT 05559411)

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  42. Abstract PO1-23-02: Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  43. Abstract PO1-19-06: Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: the randomized Neo-ACT trial

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  44. Abstract PO3-23-03: Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  45. Abstract GS02-06: Recurrence-free survival following sentinel node-positive breast cancer without completion axillary lymph node dissection – first results from the international randomized SENOMAC trial

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  46. Abstract PO1-19-03: The T-REX trial: a randomized international non-inferiority trial on Tailored Regional EXternal beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases

    Article • Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  47. Which real indications remain for mastectomy?

    Article • The Lancet Regional Health - Americas, May 2024, Elsevier

    Dr Jana de Boniface

  48. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2024, New England Journal of Medicine (NEJM/MMS)

    Dr Jana de Boniface

  49. Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project

    Article • BMJ Open, April 2024, BMJ

    Dr Jana de Boniface

  50. Targeted axillary dissection: worldwide variations in clinical practice

    Article • Breast Cancer Research and Treatment, January 2024, Springer Science + Business Media

    Dr Jana de Boniface

  51. National long-term patient-reported outcomes following mastectomy with or without breast reconstruction: The Swedish Breast Reconstruction Outcome Study Part 2 (SweBRO 2)

    Article • BJS Open, January 2024, Oxford University Press (OUP)

    Dr Jana de Boniface

  52. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    Article • Annals of Oncology, November 2023, Elsevier

    Dr Jana de Boniface

  53. Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

    Article • Breast Cancer Research and Treatment, September 2023, Springer Science + Business Media

    Dr Jana de Boniface

  54. Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial

    Article • BMJ Open, September 2023, BMJ

    Dr Jana de Boniface

  55. The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus

    Article • EClinicalMedicine, July 2023, Elsevier

    Dr Jana de Boniface

  56. Uncertainties and controversies in axillary management of patients with breast cancer

    Article • Cancer Treatment Reviews, June 2023, Elsevier

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  57. MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Jana de Boniface

  58. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

    Article • European Journal of Cancer, March 2023, Elsevier

    Dr Jana de Boniface

  59. Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)

    Article • Cancers, February 2023, MDPI AG

    Dr Jana de Boniface

  60. Axillary staging in node-positive breast cancer converting to node negativity through neoadjuvant chemotherapy: Current evidence and perspectives

    Article • Scandinavian Journal of Surgery, January 2023, SAGE Publications

    Dr Jana de Boniface

  61. Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy

    Article • Breast Care, January 2023, Karger Publishers

    Dr Jana de Boniface

  62. Capsular inflammation after immediate breast reconstruction – Gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts

    Article • Journal of Plastic Reconstructive & Aesthetic Surgery, January 2023, Elsevier

    Dr Jana de Boniface

  63. Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women

    Article • BJS, December 2022, Oxford University Press (OUP)

    Dr Jana de Boniface

  64. Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

    Article • PLOS One, October 2022, PLOS

    Dr Jana de Boniface

  65. Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey

    Article • Archives of Gynecology and Obstetrics, October 2022, Springer Science + Business Media

    Dr Jana de Boniface

  66. Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction

    Article • JAMA Network Open, September 2022, American Medical Association (AMA)

    Dr Jana de Boniface

  67. Long-term outcomes of implant-based immediate breast reconstruction with and without radiotherapy: a population-based study

    Article • BJS, August 2022, Oxford University Press (OUP)

    Dr Jana de Boniface

  68. Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women

    Article • BJS, August 2022, Oxford University Press (OUP)

    Dr Jana de Boniface

  69. Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey

    Article • BJS, June 2022, Oxford University Press (OUP)

    Dr Jana de Boniface

  70. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

    Article • The Breast, June 2022, Elsevier

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  71. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

    Article • The Breast, June 2022, Elsevier

    Dr Jana de Boniface

  72. AXSANA – AXillary Surgery After NeoAdjuvant Treatment: Eine prospektive, multizentrische Kohortenstudie der EUBREAST-Studiengruppe zur Bewertung verschiedener chirurgischer Verfahren des axillären Stagings bei initial nodal-positiven PatientInnen nach ...

    Article • Geburtshilfe und Frauenheilkunde, June 2022, Thieme Publishing Group

    Dr Jana de Boniface

  73. 120P AXSANA (AXillary Surgery After NeoAdjuvant Treatment) EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoa...

    Article • Annals of Oncology, May 2022, Elsevier

    Dr Jana de Boniface

  74. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

    Article • Breast Cancer Research and Treatment, April 2022, Springer Science + Business Media

    Dr Jana de Boniface

  75. Abstract OT1-04-04: AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node bi...

    Article • Cancer Research, February 2022, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  76. Abstract P1-01-16: Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

    Article • Cancer Research, February 2022, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  77. Eradication of Potential In-Transit Metastasis in Breast-Conserving Surgery—Reply

    Article • JAMA Surgery, February 2022, American Medical Association (AMA)

    Dr Jana de Boniface

  78. Effect of radiotherapy on expanders and permanent implants in immediate breast reconstruction: long-term surgical and patient-reported outcomes in a large multicentre cohort

    Article • BJS, October 2021, Oxford University Press (OUP)

    Dr Jana de Boniface

  79. ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

    Article • Annals of Surgical Oncology, October 2021, Springer Science + Business Media

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  80. Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

    Article • Annals of Surgical Oncology, October 2021, Springer Science + Business Media

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  81. Survival in breast cancer patients with a delayed DIEP flap breast reconstruction after adjustment for socioeconomic status and comorbidity

    Article • The Breast, October 2021, Elsevier

    Dr Jana de Boniface

  82. Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy

    Article • Geburtshilfe und Frauenheilkunde, October 2021, Thieme Publishing Group

    Dr Jana de Boniface

  83. Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing ...

    Article • BMJ Open, September 2021, BMJ

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  84. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status

    Article • JAMA Surgery, July 2021, American Medical Association (AMA)

    Dr Jana de Boniface

  85. Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease

    Article • JAMA Surgery, June 2021, American Medical Association (AMA)

    Dr Jana de Boniface

  86. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial

    Article • BJS, May 2021, Oxford University Press (OUP)

    Dr Jana de Boniface

  87. Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

    Article • BJS, May 2021, Oxford University Press (OUP)

    Dr Jana de Boniface

  88. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

    Article • Cancers, March 2021, MDPI AG

    Dr Jana de Boniface

  89. Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial

    Article • BJS, January 2021, Oxford University Press (OUP)

    Dr Jana de Boniface

  90. Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer

    Article • BJS Open, January 2021, Oxford University Press (OUP)

    Dr Jana de Boniface

  91. Breast reconstruction patterns from a Swedish nation-wide survey

    Article • European Journal of Surgical Oncology, October 2020, Elsevier

    Dr Jana de Boniface

  92. AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinica...

    Article • Geburtshilfe und Frauenheilkunde, October 2020, Thieme Publishing Group

    Dr Jana de Boniface

  93. Target Lymph Node Biopsy (TLNB) nach Kohlenstoffmarkierung bei Mammakarzinom-Patientinnen im Rahmen der primären Systemtherapie – Ergebnisse der TATTOO-Studie

    Article • Geburtshilfe und Frauenheilkunde, October 2020, Thieme Publishing Group

    Dr Jana de Boniface

  94. Risk factors for implant failure following revision surgery in breast cancer patients with a previous immediate implant-based breast reconstruction

    Article • Breast Cancer Research and Treatment, September 2020, Springer Science + Business Media

    Dr Jana de Boniface

  95. Knowledge gaps in oncoplastic breast surgery

    Article • The Lancet Oncology, August 2020, Elsevier

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  96. AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinica...

    Article • Geburtshilfe und Frauenheilkunde, July 2020, Thieme Publishing Group

    Dr Jana de Boniface

  97. TLNB (Target-Lymph-Node-Biopsy) nach Kohlenstoffmarkierung bei Mammakarzinom-Patientinnen nach primärer Systemtherapie Ergebnisse der TATTOO-Studie

    Article • Geburtshilfe und Frauenheilkunde, July 2020, Thieme Publishing Group

    Dr Jana de Boniface

  98. Abstract OT3-01-01: Feasibility of carbon tattooing for targeted lymph node biopsy in breast cancer patients treated by primary systemic therapy (TATTOO trial)

    Article • Cancer Research, February 2020, American Association for Cancer Research (AACR)

    Dr Jana de Boniface

  99. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

    Article • Journal of Clinical Investigation, February 2020, American Society for Clinical Investigation

    Dr Jana de Boniface

  100. Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019

    Article • Current Opinion in Obstetrics & Gynecology, February 2020, Wolters Kluwer Health

    Dr Jana de Boniface

  101. Influence of socioeconomic status on immediate breast reconstruction rate, patient information and involvement in surgical decision-making

    Article • BJS Open, January 2020, Oxford University Press (OUP)

    Dr Jana de Boniface

  102. The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

    Article • Breast Cancer Research and Treatment, January 2020, Springer Science + Business Media

    Dr Jana de Boniface

  103. Immediate Breast Reconstruction

    Article • Breast Care, January 2020, Karger Publishers

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  104. Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information

    Article • Breast Cancer Research and Treatment, November 2019, Springer Science + Business Media

    Dr Jana de Boniface

  105. Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer

    Article • Breast Cancer Research and Treatment, June 2019, Springer Science + Business Media

    Dr Jana de Boniface

  106. Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant

    Article • Breast Cancer Research and Treatment, January 2019, Springer Science + Business Media

    Dr Jana de Boniface

  107. A gap analysis of opportunities and priorities for breast surgical research

    Article • The Lancet Oncology, January 2019, Elsevier

    Dr Jana de Boniface

  108. Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

    Article • Breast Cancer Research and Treatment, September 2018, Springer Science + Business Media

    Prof. Dr. med. Yves Harder, Dr Jana de Boniface

  109. Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation

    Article • BJS, June 2018, Wiley

    Dr Jana de Boniface

  110. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes

    Article • Breast Cancer Research and Treatment, May 2018, Springer Science + Business Media

    Dr Jana de Boniface

  111. Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction

    Article • BJS, April 2018, Wiley

    Dr Jana de Boniface

  112. Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting

    Article • Breast Care, January 2018, Karger Publishers

    Dr Jana de Boniface

  113. What Is the Best Management of cN0pN1(sn) Breast Cancer Patients

    Article • Breast Care, January 2018, Karger Publishers

    Dr Jana de Boniface

  114. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

    Article • BMC Cancer, May 2017, Springer Science + Business Media

    Dr Jana de Boniface

  115. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer

    Article • Breast Cancer Research and Treatment, February 2017, Springer Science + Business Media

    Dr Jana de Boniface

  116. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer

    Article • Breast Cancer Research and Treatment, February 2017, Springer Science + Business Media

    Dr Jana de Boniface

  117. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study

    Article • BJS, January 2017, Oxford University Press (OUP)

    Dr Jana de Boniface

  118. Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision

    Article • The Breast, December 2016, Elsevier

    Dr Jana de Boniface

  119. National study of the impact of patient information and involvement in decision-making on immediate breast reconstruction rates

    Article • BJS, August 2016, Wiley

    Dr Jana de Boniface

  120. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

    Article • Journal of Translational Medicine, July 2016, Springer Science + Business Media

    Dr Jana de Boniface

  121. The oncological safety of nipple-sparing mastectomy – A Swedish matched cohort study

    Article • European Journal of Surgical Oncology, October 2014, Elsevier

    Dr Jana de Boniface

  122. Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis

    Article • British Journal of Cancer, July 2014, Springer Science + Business Media

    Dr Jana de Boniface

  123. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinomain situ

    Article • BJS, February 2014, Oxford University Press (OUP)

    Dr Jana de Boniface

  124. Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort

    Article • Breast Cancer Research and Treatment, November 2013, Springer Science + Business Media

    Dr Jana de Boniface

  125. Authors' reply: Causes of false-negative sentinel node biopsy in patients with breast cancer (Br J Surg2013; 100: 775-783)

    Article • BJS, August 2013, Wiley

    Dr Jana de Boniface

  126. High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes

    Article • PLOS One, February 2013, PLOS

    Dr Jana de Boniface

  127. Causes of false-negative sentinel node biopsy in patients with breast cancer

    Article • BJS, February 2013, Wiley

    Dr Jana de Boniface

  128. Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

    Article • Journal of Translational Medicine, January 2013, Springer Science + Business Media

    Dr Jana de Boniface

  129. Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

    Article • OncoImmunology, November 2012, Taylor & Francis

    Dr Jana de Boniface

  130. Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients

    Article • International Journal of Cancer, January 2012, Wiley

    Dr Jana de Boniface

  131. Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score

    Article • Breast Cancer Basic and Clinical Research, January 2012, Libertas Academica, Ltd.

    Dr Jana de Boniface

  132. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer

    Article • BJS, December 2011, Wiley

    Dr Jana de Boniface

  133. Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function

    Article • International Journal of Cancer, August 2011, Wiley

    Dr Jana de Boniface

  134. Breast Cancer Survival in Relation to the Metastatic Tumor Burden in Axillary Lymph Nodes

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    Dr Jana de Boniface

  135. Axillary Recurrence Rate After Negative Sentinel Node Biopsy in Breast Cancer

    Article • Annals of Surgery, January 2008, Wolters Kluwer Health

    Dr Jana de Boniface

  136. Sentinel node biopsy for breast cancer larger than 3 cm in diameter

    Article • BJS, January 2007, Wiley

    Dr Jana de Boniface